Welcome to Gene on Link
Contact Us For More Information

Why Genetics Testing Is Important

Genetic testing is important for cancer treatment for several reasons:

  1. Personalized Treatment Approaches:
    Genetic testing can provide information about specific mutations or alterations in the tumor’s DNA. This information can help oncologists tailor treatment plans based on the unique genetic profile of the cancer. Some genetic mutations may respond better to certain targeted therapies, allowing for more effective and personalized treatment strategies.
  2. Predicting Treatment Response:Genetic testing can help predict how a patient’s cancer is likely to respond to certain treatments. Understanding the genetic makeup of the tumor can guide the selection of chemotherapy agents or other targeted therapies that are more likely to be effective, potentially improving treatment outcomes.
  3. Clinical Trial Eligibility:
    Genetic testing results may identify individuals who are eligible for participation in clinical trials studying new treatments or therapies specific to certain genetic mutations. Participation in clinical trials can provide access to cutting-edge treatments and contribute to advancements in colorectal cancer research.

In summary, genetic testing plays a crucial role in cancer treatment by providing valuable information about the genetic factors influencing the disease. This knowledge enables more personalized and targeted approaches to treatment, improves the prediction of treatment outcomes, and contributes to the overall management of the disease for both the patient and their family.

Cancer Companion Diagnostic Tests

GOL cancer panel:  

Cancer Therapeutics and Monitoring (Targeted Therapy & Precision Medicine)

Research NGS Services

‧Whole Genome Resequencing (WGS)/Whole Exome Resequencing (WES)

‧Target resequencing

‧RNA-Sequencing

‧Gene Annotation

Respiratory Viruses Real-Time PCR Test

We are dedicated to the development of various molecular diagnostic technologies, including pathogen nucleic acid molecular testing and the development of various cancer genetics tests using Next Generation Sequencing (NGS) technology. During the COVID-19 pandemic, we have invested in our research and production technology to develop SARS-CoV-2 PCR testing reagents. We have obtained Emergency Use Authorization (EUA) both in Taiwan and the United States. Gene on Link laboratory also has played a pivotal role in supporting public health initiatives. We have forged strong partnerships with local clinical laboratories and hospitals to enhance our capabilities in the fight against infectious diseases.

RT-PCR COVID-19 Test

The RT-PCR COVID-19 Test Service employs advanced Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology to accurately and rapidly detect the presence of the SARS-CoV-2 virus, which causes COVID-19.

RT-PCR Influenza Test

The RT-PCR Influenza Testing Service utilizes advanced Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology to rapidly and accurately detect influenza viruses, including both Influenza A and B.

RT-PCR RSV Test

The RT-PCR RSV Test uses Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology to detect Respiratory Syncytial Virus (RSV) with high precision and speed. This test is essential for diagnosing RSV, especially in vulnerable populations such as infants, the elderly, and those with weakened immune systems.

RT-PCR SARS-CoV-2/Flu/RSV Test

The RT-PCR SARS-CoV-2/Flu/RSV Test is a comprehensive diagnostic tool that uses Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology to simultaneously detect three major respiratory pathogens: SARS-CoV-2 (the virus causing COVID-19), Influenza A and B, and Respiratory Syncytial Virus (RSV). This combined test is highly valuable during respiratory illness seasons and for patients presenting with overlapping symptoms, as it enables healthcare providers to quickly identify the specific virus involved, aiding in accurate diagnosis and tailored treatment.